Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2021-A02939-32 | Other Identifier | ID RCB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Hemodynamic instability episodes are a frequent complication of renal replacement therapies in critically ill patients, and their incidence is associated with worse survival. Hypovolemia, identified by the existence of biventricular preload dependence, is responsible for one episode out of two, and may justify a decrease in or cessation of fluid removal by net ultrafiltration (UF). To date, preload dependence is most frequently identified by evaluating the effects on cardiac output of postural changes (passive leg raising), impact of cardio-pulmonary interactions in ventilated patients, or fluid challenge. However, none of these tests may help identify a patient whose cardiac output is at risk of becoming preload dependent, that is situated at the inflexion point of the Frank Starling curve.
Our study aims to evaluate the effects on cardiac output (measured by a transpulmonary thermodilution technique) of 2 net ultrafiltration challenges, consisting fast removal of 250 ml of ultrafiltrate over 15 and 30 minutes respectively, and compare their diagnostic performance to the reference technique of preload dependence assessed by postural changes (passive leg raising) performed after the UF challenge.
Enrolled participants will undergo both UF challenges, following a randomized crossover design, in which the order of UF challenge duration (15 or 30 minutes) is randomized, separated by a washout period of 24 hours.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Fast to Slow Group | Experimental | The Fast to Slow Group corresponds to enrolled patients randomized, following the sequential crossover design, to first perform the fast UF challenge immediately after inclusion, followed by the slow UF challenge after a washout period of 24 hours. |
|
| Slow to Fast Group | Experimental | The Slow to Fast Group corresponds to enrolled patients randomized, following the sequential crossover design, to first perform the slow UF challenge immediately after inclusion, followed by the fast UF challenge after a washout period of 24 hours. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Fast ultrafiltration challenge | Diagnostic Test | The fast ultrafiltration challenge will be performed once in all enrolled participants, in the order defined by randomization. The fast ultrafiltration challenge consists of the net removal of 250 ml of ultrafiltrate by setting net ultrafiltration rate to 1000 ml/h, applied for 15 minutes. The cardiac output will be measured before and after the UF challenge, by mean of the transpulmonary thermodilution technique, and its relative variation from baseline will be quantified to evaluate the impact of the UF challenge on cardiac preload. The UF challenge will be preceded and immediately followed by a postural change maneuver to assess the presence or absence of preload dependence. The postural change maneuver is positive in case of a +10% variation in continuous cardiac index over 1 minute, and is considered as the reference diagnostic test to which UF challenge diagnostic performance will be compared. |
| Measure | Description | Time Frame |
|---|---|---|
| Diagnostic Performance of the Net Ultrafiltration (UF NET) Challenge to Detect de Novo Preload Dependence | The diagnostic performance was assessed using the area under the receiver-operating curve (AUROC) of the relative variation in calibrated cardiac index, measured at baseline and at the end of the challenge, and compared to the reference standard consisting in the result of a postural maneuver (passive leg raising or Trendelenburg) evaluating preload dependence using pulse-contour continuous cardiac index variation (positive if > 10% or negative if ≤ 10%) performed at the end of the challenge. | Baseline and immediately at the end ot each UF NET challenge (approximately 15-30 minutes, 1 day apart) |
| Measure | Description | Time Frame |
|---|---|---|
| Respective Diagnostic Performance of the Fast and Slow Net Ultrafiltration (UF NET) Challenge to Detect de Novo Preload Dependence | The respective diagnostic performance of fast and slow challenges was assessed using the area under the receiver-operating curve (AUROC) of the relative variation in calibrated cardiac index, measured at baseline and at the end of fast and slow challenges, and compared to the reference standard consisting in the result of a postural maneuver (passive leg raising or Trendelenburg) evaluating preload dependence using pulse-contour continuous cardiac index variation (positive if > 10% or negative if ≤ 10%) performed at the end of the challenge. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Laurent BITKER, MD | Hospices Civils de Lyon | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Intensive Care, Croix Rousse hospital, Hospices Civils de Lyon | Lyon | 69004 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41121412 | Derived | Biscarrat C, Deniel G, Chivot M, Yonis H, Chauvelot L, Mezidi M, Richard JC, Bitker L. Diagnostic performance of a 250-ml net ultrafiltration challenge to identify risk of preload-dependence in critically ill patients undergoing continuous renal replacement therapy: a randomized, cross-over trial. Crit Care. 2025 Oct 21;29(1):446. doi: 10.1186/s13054-025-05674-3. |
Not provided
Not provided
20 patients were randomized. Of the 44 not randomized, 44 met inclusion criteria and met exclusion criteria.
64 patients were screened between june 2022 and december 2024
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Slow to Fast Group | The Slow to Fast Group corresponds to enrolled patients randomized, following the sequential crossover design, to first perform the slow ultrafiltration challenge immediately after inclusion, followed by the fast ultrafiltration challenge after a washout period of 24 hours. Fast ultrafiltration challenge consists of the net removal of 250 ml of ultrafiltrate by setting net ultrafiltration rate to 1000 ml/h, applied for 15 minutes. Slow ultrafiltration challenge consists of the net removal of 250 ml of ultrafiltrate by setting net ultrafiltration rate to 500 ml/h, applied for 30 minutes. |
| FG001 | Fast to Slow Group | The Fast to Slow Group corresponds to enrolled patients randomized, following the sequential crossover design, to first perform the fast UF challenge immediately after inclusion, followed by the slow UF challenge after a washout period of 24 hours. Fast ultrafiltration challenge consists of the net removal of 250 ml of ultrafiltrate by setting net ultrafiltration rate to 1000 ml/h, applied for 15 minutes. Slow ultrafiltration challenge consists of the net removal of 250 ml of ultrafiltrate by setting net ultrafiltration rate to 500 ml/h, applied for 30 minutes. |
| Title | Milestones | Reasons Not Completed | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| First Challenge (15 or 30 Minutes) |
| ||||||||||||||||
| Wash-out Period (24 to 48h) |
| ||||||||||||||||
| Second Challenge (15 or 30 Minutes) |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Fast to Slow Group | The Fast to Slow Group corresponds to enrolled patients randomized, following the sequential crossover design, to first perform the fast UF challenge immediately after inclusion, followed by the slow UF challenge after a washout period of 24 hours. Fast ultrafiltration challenge consists of the net removal of 250 ml of ultrafiltrate by setting net ultrafiltration rate to 1000 ml/h, applied for 15 minutes. Slow ultrafiltration challenge consists of the net removal of 250 ml of ultrafiltrate by setting net ultrafiltration rate to 500 ml/h, applied for 30 minutes. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Median |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Diagnostic Performance of the Net Ultrafiltration (UF NET) Challenge to Detect de Novo Preload Dependence | The diagnostic performance was assessed using the area under the receiver-operating curve (AUROC) of the relative variation in calibrated cardiac index, measured at baseline and at the end of the challenge, and compared to the reference standard consisting in the result of a postural maneuver (passive leg raising or Trendelenburg) evaluating preload dependence using pulse-contour continuous cardiac index variation (positive if > 10% or negative if ≤ 10%) performed at the end of the challenge. | All enrolled patients underwent two UF NET challenges, one fast and one slow, consisting in the removal of 250 ml of ultrafiltrate in randomized order and in a cross-over design (with a 24h wash-out period between challenged). 4 patients did not perform the second challenge due to the presence of predefined exit criteria during the wash-out period, as defined by the allocations sequence. | Posted | Mean | 95% Confidence Interval | Proportion probability (0 to 1) | Baseline and immediately at the end ot each UF NET challenge (approximately 15-30 minutes, 1 day apart) | UF NET challenges | UF NET challenges |
From enrollment until end of follow-up (8h after the end of the second challenge, that is within a maximum time range of 56 hours avec enrollment)
The overall mortality rate is reported to the number of participants at risk (N=20).
Other severe adverse events are reported to the number of challenges at risk (N=36).
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Fast UF NET Challenge | Fast ultrafiltration challenge consists of the net removal of 250 ml of ultrafiltrate by setting net ultrafiltration rate to 1000 ml/h, applied for 15 minutes. |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Norepinephrine increase during the UF NET challenge | Cardiac disorders | Protocol-defined | Systematic Assessment |
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr Laurent BITKER | Hospices Civils de Lyon | 4 26 10 92 69 | +33 | laurent.bitker@chu-lyon.fr |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Mar 16, 2022 | Nov 7, 2025 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D058186 | Acute Kidney Injury |
| ID | Term |
|---|---|
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Slow ultrafiltration challenge | Diagnostic Test | The slow ultrafiltration challenge will be performed once in all enrolled participants, in the order defined by randomization. The slow ultrafiltration challenge consists of the net removal of 250 ml of ultrafiltrate by setting net ultrafiltration rate to 500 ml/h, applied for 30 minutes. The cardiac output will be measured before and after the UF challenge, by mean of the transpulmonary thermodilution technique, and its relative variation from baseline will be quantified to evaluate the impact of the UF challenge on cardiac preload. The UF challenge will be preceded and immediately followed by a postural change maneuver to assess the presence or absence of preload dependence. The postural change maneuver is positive in case of a +10% variation in continuous cardiac index over 1 minute, and is considered as the reference diagnostic test to which UF challenge diagnostic performance will be compared. |
|
| Between baseline and end of the UF NET challenge |
| Preload Dependence Prevalence After a UF NET Challenge | The rate (in %) of UF NET challenges after which a preload-dependence status was identified using the reference diagnostic method, consisting of a postural maneuver (passive leg raising or Trendelenburg maneuver) during which the relative variation in pulse-contour continuous cardiac index was assessed over 1 minute. The test was positive if the relative variation in pulse-contour continuous cardiac index increased by more than 10% during the maneuver, and negative otherwise. | At the end of the UF NET challenge |
| NOT COMPLETED |
|
|
| COMPLETED |
|
| NOT COMPLETED |
|
| BG001 | Slow to Fast Group | The Slow to Fast Group corresponds to enrolled patients randomized, following the sequential crossover design, to first perform the slow UF challenge immediately after inclusion, followed by the fast UF challenge after a washout period of 24 hours. Fast ultrafiltration challenge consists of the net removal of 250 ml of ultrafiltrate by setting net ultrafiltration rate to 1000 ml/h, applied for 15 minutes. Slow ultrafiltration challenge consists of the net removal of 250 ml of ultrafiltrate by setting net ultrafiltration rate to 500 ml/h, applied for 30 minutes. |
| BG002 | Total | Total of all reporting groups |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race and Ethnicity Not Collected | Race and Ethnicity were not collected from any participant. | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
| Sepsis-related Organ Failure Assessment (SOFA) | Total SOFA score, ranging from 0 (lowest possible value) to 24 (highest possible value), constructed on the addition of the sub-scores related to 6 organ-failure domains (hemodynamic, respiratory, neurological, renal, liver and coagulation), each with a value between 0 and 4. Higher score values indicate greater clinical severity. | Median | Inter-Quartile Range | Units on a scale |
|
| Norepinephrine dose (tartrate formula) | Median | Inter-Quartile Range | µg/kg/min |
|
| ID | Title | Description |
|---|
| OG000 | All UF NET Challenges | All completed UF NET challenges (irrespective of their duration, i.e. fast or slow) are pooled and analyzed together for the primary outcome. |
|
|
|
| Secondary | Respective Diagnostic Performance of the Fast and Slow Net Ultrafiltration (UF NET) Challenge to Detect de Novo Preload Dependence | The respective diagnostic performance of fast and slow challenges was assessed using the area under the receiver-operating curve (AUROC) of the relative variation in calibrated cardiac index, measured at baseline and at the end of fast and slow challenges, and compared to the reference standard consisting in the result of a postural maneuver (passive leg raising or Trendelenburg) evaluating preload dependence using pulse-contour continuous cardiac index variation (positive if > 10% or negative if ≤ 10%) performed at the end of the challenge. | All enrolled patients underwent two UF NET challenges, one fast and one slow, consisting in the removal of 250 ml of ultrafiltrate in randomized order and in a cross-over design (with a 24h wash-out period between challenged). 4 patients did not perform the second challenge (1 fast and 3 slow) due to the presence of predefined exit criteria during the wash-out period. | Posted | Mean | 95% Confidence Interval | Proportion probability (0 to 1) | Between baseline and end of the UF NET challenge | UF NET Challenges | UF NET Challenges |
|
|
|
| Secondary | Preload Dependence Prevalence After a UF NET Challenge | The rate (in %) of UF NET challenges after which a preload-dependence status was identified using the reference diagnostic method, consisting of a postural maneuver (passive leg raising or Trendelenburg maneuver) during which the relative variation in pulse-contour continuous cardiac index was assessed over 1 minute. The test was positive if the relative variation in pulse-contour continuous cardiac index increased by more than 10% during the maneuver, and negative otherwise. | Five challenges (4 fast, 1 slow, all related to the first visit) were a posteriori identified as being preload-dependent prior to challenge start, leaving 31 challenges (in 17 patients) out of a total of 36 challenges (in 20 patients). This analysis was a priori planned to be performed on all UF NET challenges (irrespective of their duration, slow or fast), and each study groups (slow and fast, respectively). | Posted | Count of Units | UF NET challenges | At the end of the UF NET challenge | UF NET challenges | UF NET challenges |
|
|
|
| 0 |
| 10 |
| 11 |
| 19 |
| 0 |
| 19 |
| EG001 | Slow UF NET Challenge | Slow ultrafiltration challenge consists of the net removal of 250 ml of ultrafiltrate by setting net ultrafiltration rate to 500 ml/h, applied for 30 minutes. | 0 | 10 | 13 | 17 | 0 | 17 |
| Change in sedation dose | Nervous system disorders | Protocol-defined | Systematic Assessment |
|
| Hemodynamic instability episode during the 8h follow-up period after the challenge | Cardiac disorders | Protocol-defined | Systematic Assessment | Hemodynamic instability was defined as the occurence of tachycardia (>120 bpm), hypotension (MAP < 65 mmHg with a therapeutic intervention), drop in cardiac index > 15%, new onset mottles. Multiple episodes could be reported in the same patient. |
|
Not provided
Not provided
Not provided
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |